Recognizing the duty of the Federal Government to lead the world in biomedical research.

H. Res. 601 is a non-binding House resolution that states the sense of Congress that the Federal Government must lead the world in biomedical research. It frames NIH and federal biomedical funding as a national asset, outlines principles to protect scientific integrity, and sets aspirational policy goals. Notably, it calls for doubling federal biomedical research investment over the next decade, enhanced training and retention of the biomedical workforce, and increased collaboration across government, academia, industry, and health systems. The resolution emphasizes keeping science insulated from political interference, expanding basic and translational research, funding high-risk/high-reward projects, and accelerating the integration of research findings into clinical practice. It also lists targeted health priorities intended to guide future investments, such as aging, chronic disease, cancer, neurodegenerative diseases, infectious threats, organ transplantation, and health equity in trials. As a resolution, it does not itself create new laws or mandatory funding, but it communicates Congress’s policy preferences and could influence future budget decisions, agency priorities, and oversight related to biomedical research.